Editas Medicine, Inc. (EDIT)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

12 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014
Revenue$40.5M$32.3M$78.1M$19.7M$25.5M$90.7M$20.5M$31.9M$13.7M$6.1M
Research & development$90.0M$199.2M$177.7M$175.0M$142.5M$158.0M$96.9M$90.7M$83.2M$57.0M$18.8M$5.1M
Operating expenses$200.5M$283.5M$247.3M$245.7M$218.7M$225.6M$161.5M$145.7M$133.7M$103.2M$36.9M$12.7M
Operating income−$160.0M−$251.2M−$169.2M−$225.9M−$193.1M−$134.8M−$140.9M−$113.7M−$119.9M−$97.2M−$35.3M−$12.7M
Net income−$160.1M−$237.1M−$153.2M−$220.4M−$192.5M−$116.0M−$133.7M−$110.0M−$120.3M−$97.2M−$72.9M−$13.7M
Basic EPSper diluted share-$1.80-$2.88-$2.02-$3.21-$2.85-$1.98-$2.68-$2.33-$2.98-$3.02-$28.55-$12.46
Diluted EPSper diluted share-$1.80-$2.88-$2.02-$3.21-$2.85-$1.98-$2.68-$2.33-$2.98-$3.02-$28.55-$12.46

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)26$283.8K disclosed value
26 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 3, 2026Form 4 · 10b5-1Parison AmySVP, Chief Financial OfficerSellCommon Stock464$2.70$1.3K15.0K
Jun 3, 2026Form 4 · 10b5-1O'Neill Gilmore NeilCEOSellCommon Stock15.4K$2.70$41.5K248.3K
Jun 3, 2026Form 4 · 10b5-1Burkly LindaEVP, CHIEF SCIENTIFIC OFFICERSellCommon Stock731$2.70$2.0K67.3K
Mar 3, 2026Form 4 · 10b5-1O'Neill Gilmore NeilCEOSellCommon Stock5.4K$2.02$10.9K263.7K
Mar 3, 2026Form 4 · 10b5-1Parison AmySVP, Chief Financial OfficerSellCommon Stock474$2.02$957.4815.4K